Get published

Techno Trends

Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.

PBS Biotech Launches Breakthrough MiniPRO™ Multi-Parallel Bioreactor Platform for Cell Therapy Process Development

PBS Biotech has unveiled MiniPRO™, a new multi-parallel Vertical-Wheel® bioreactor platform designed to accelerate high-throughput cell therapy process development....

Sound Pharmaceuticals Receives FDA Breakthrough Therapy Designation for SPI-1005 in Meniere’s Disease

Sound Pharmaceuticals (SPI) has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to its investigational oral drug, SPI-1005, for the treatment...

FDA Grants Breakthrough Status to BeOne’s Sonrotoclax for Mantle Cell Lymphoma

BeOne Medicines has announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation (BTD) for sonrotoclax, an investigational BCL2 inhibitor, for adults with relapsed or refractory mantle cell lymphoma (MCL). ...

MicrobiotiX Secures IND Approval for Korea’s First Human Trial of Bacteriophage Therapy MP101

MicrobiotiX Co., Ltd., has received Investigational New Drug (IND) approval from Korea’s Ministry of Food and Drug Safety (MFDS) for its investigational drug MP101, developed for the treatment of acute pneumonia. ...

Augurex Life Sciences Receives FDA Breakthrough Device Designation for SPINEstat® Diagnostic Test for Axial Spondyloarthritis

Augurex Life Sciences Corp., a developer of autoimmune diagnostic tests, has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its SPINEstat® 14-3-3eta Autoantibody Multiplex Immunoassay Test. ...

Electra Therapeutics Receives FDA Breakthrough Therapy and EMA PRIME Designations for ELA026 in sHLH

Electra, a clinical-stage biotechnology company developing novel treatments for immune and cancer-related diseases, announced that its lead candidate ELA026 has granted Breakthrough Therapy Designation (BTD)...

Bicara Therapeutics Secures Breakthrough Therapy Status for Ficerafusp Alfa

Bicara Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to ficerafusp alfa in combination with pembrolizumab for the first-line treatment...

Taysha’s TSHA-102 Received FDA Breakthrough Therapy Designation for Rett Syndrome

Taysha Gene Therapies has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSHA-102, an intrathecal AAV9 gene therapy for Rett syndrome....